# Sarcopenia and NMIBC Prognosis Study

> **NCT07285408** · — · NOT_YET_RECRUITING · sponsor: **General Hospital Sveti Duh** · enrollment: 150 (estimated)

## Conditions studied

- Bladder Cancer Cell Transitional

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07285408
- **Lead sponsor:** General Hospital Sveti Duh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-02
- **Primary completion:** 2027-07-12
- **Final completion:** 2029-07-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07285408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07285408, "Sarcopenia and NMIBC Prognosis Study". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07285408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*